MiMedx

mimedx.com · Marietta, United States of America

MiMedx is a biopharmaceutical company that develops and commercializes regenerative biologics derived from human placental tissue to treat chronic wounds, burns, and musculoskeletal conditions. It supplies allograft products primarily to hospitals, wound care centers, and physicians, generating revenue through the sale of these regulated therapeutic products. The company focuses on evidence-based, minimally invasive treatments that support tissue repair and reduce healing times for patients with complex conditions.

Revenue
$250M - $1B
Employees
201 - 1,000
Founded
2008
Headquarters
Marietta, United States of America

MiMedx customers on Arbolus

Total customers 20 19 current · 1 former
Reviews growth 16 new reviews since Mar 2026

Customers who reviewed MiMedx

Seniority of MiMedx customers

Most people who reviewed MiMedx hold C-Suite roles (79%), followed by Manager (16%) and Director (5%).

  • C-Suite 79%
  • Manager 16%
  • Director 5%

Customers sample

Not specified Director NPS 10
Other Generalist Manager NPS 6
Other Generalist C-Suite NPS 7

Employer names and spend open once the report publishes.

What 19 Arbolus experts think of MiMedx

Overall sentiment: Positive

NPS scores span 4 to 10, with a weighted average toward higher values, as 35% of experts are strong promoters (NPS 9-10) and another 40% are passives (NPS 7-8). Only a small segment (15%) registers detractor scores (6 or below). Renewal intent is explicit and high among large spenders and influencers, with the bulk of user respondents lacking clarity on renewal but reporting sustained usage. Most experts are in the more-than-a-year implementation stage, reinforcing stickiness. The key data theme is stable, positive sentiment especially aligned to high-value decision makers.

Tell us when the MiMedx report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

5 Net Promoter Score, from 19 scored reviews
  • Promoters 5
  • Passives 10
  • Detractors 4

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 40%
  • Will renew 2
  • Undecided 3
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 40% 5 answers
  • 8.5/10 Average score from customers who will renew
  • 7.7/10 Average score from undecided customers

Top alternatives

Most weighed by MiMedx customers

For people who use MiMedx

Do you use MiMedx at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 19 customers of MiMedx have already contributed

Takes a few minutes. Your identity stays anonymous.